PFE PFIZER INC
2026Q1 · CUSIP 717081103 · Big Pharma · Sector: Healthcare & Biotech
Lit · Institutions accelerating in
Holders
2,933
Δ holders QoQ
+22
Breadth percentile
Top 14%
Whale holders
336
Δ whales
-5
Inst. holding value
$104.2B
New positions
251
Closed positions
229
Price momentum (1Q)
-5.9%
Put / Call
56/70
Breadth history (34 quarters)
Past Lit Events & Aftermath 13 lit events
| Period | Percentile | Next-1Q return | Next-2Q return |
|---|---|---|---|
| 2026Q1 | Top 14% | — | — |
| 2025Q4 | Top 4% | -5.9% | — |
| 2024Q4 | Top 5% | -8.3% | +2.7% |
| 2024Q3 | Top 8% | +7.5% | -4.0% |
| 2022Q4 | Top 1% | -14.1% | -12.8% |
| 2021Q4 | Top 0% | +2.3% | -0.7% |
| 2021Q3 | Top 1% | +0.9% | +3.2% |
| 2021Q2 | Top 2% | +2.6% | +3.5% |
Options Sentiment
Put holders
56
QoQ: -6
Call holders
70
QoQ: -3
See methodology →
Fundamentals
PE (TTM)
18.9
EPS (TTM)
$1.31
EPS YoY
-5.1%
Revenue (TTM)
$63.3B
Revenue YoY
+1.4%
Net margin
11.8%
ROE
8.3%
Debt ratio
56.5%
FCF (TTM)
$9.5B
Dividend (TTM)
$1.72
Quarterly Revenue & EPS (4Y)
Quarterly figures; EPS split-adjusted, early quarters hidden when not calibrable
P/E (TTM) over time
P/E = close 47 days after quarter-end (filing date) ÷ TTM EPS then; loss quarters hidden
As of 2026-03-29 · SEC filings (XBRL)
Get the next update
2026Q2 holdings publish around Aug 15 — subscribe to receive the lists first.